COVID-19住院患者的肺动脉高压与右心室受累
这项单中心观察性横断面研究纳入200例非ICU住院COVID-19患者,均接受经胸超声心动图检查。肺动脉高压(PH)患病率为12.0%,右心室功能障碍(RVD)为14.5%。PH与更严重的SARS-CoV-2感染表现及更高的院内死亡或ICU转入率相关(41.7% vs 8.5%,p<0.001),而RVD无此关联。
要点
- 非ICU住院COVID-19患者中PH患病率12.0%,RVD患病率14.5%。
- PH与更严重的新冠感染表现及不良院内结局相关。
- RVD与既往心脏合并症负担相关,但与新冠严重程度及结局无关。
核心结论
- 在非ICU住院COVID-19患者中,PH(而非RVD)与更严重的COVID-19表现及更差的院内临床结局相关。
研究设计与样本
- 单中心、观察性、横断面研究,纳入211例非ICU住院COVID-19患者,排除11例声窗差者,最终分析200例。
- 中位年龄62岁(IQR 52-74),男性占65.5%。
- 所有患者接受单次经胸超声心动图检查。
主要发现
- PH患病率为12.0%(24/200),RVD患病率为14.5%(29/200)。
- PH患者较无PH者年龄更大、既往心脏合并症负担更高,且SARS-CoV-2感染更严重(影像学肺部受累、实验室指标及氧合状态)。
- RVD患者较无RVD者既往心脏合并症负担更高,但无更严重SARS-CoV-2感染的证据。
- PH与更高的院内死亡或ICU转入率相关(41.7% vs 8.5%,p<0.001)。
- RVD与院内死亡或ICU转入率无显著关联(17.2% vs 11.7%,p=0.404)。
关键数值与推荐
- PH定义为估测收缩期肺动脉压>35 mm Hg。
- RVD定义为三尖瓣环收缩期位移<17 mm或S波<9.5 cm/s。
- 主要终点为院内死亡或ICU转入。
临床怎么用
- 对非ICU住院COVID-19患者,超声心动图发现的PH有助于识别院内不良结局高风险人群。
- RVD在此人群中未显示与新冠严重程度或院内结局的独立关联,临床解读需结合既往心脏合并症。
局限性
- 单中心、观察性、横断面设计,样本量有限(最终分析200例)。
- 排除声窗差的患者(n=11),可能引入选择偏倚。
- PH和RVD均基于单次超声心动图估测,未行右心导管验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the prevalence, characteristics and prognostic value of pulmonary hypertension (PH) and right ventricular dysfunction (RVD) in hospitalised, non-intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19). METHODS: This single-centre, observational, cross-sectional study included 211 patients with COVID-19 admitted to non-ICU departments who underwent a single transthoracic echocardiography (TTE). Patients with poor acoustic window (n=11) were excluded. Clinical, imaging, laboratory and TTE findings were compared in patients with versus without PH (estimated systolic pulmonary artery pressure >35 mm Hg) and with versus without RVD (tricuspid annular plane systolic excursion <17 mm or S wave <9.5 cm/s). The primary endpoint was in-hospital death or ICU admission. RESULTS: A total of 200 patients were included in the final analysis (median age 62 (IQR 52-74) years, 65.5% men). The prevalence of PH and RVD was 12.0% (24/200) and 14.5% (29/200), respectively. Patients with PH were older and had a higher burden of pre-existing cardiac comorbidities and signs of more severe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (radiological lung involvement, laboratory findings and oxygenation status) compared with those without PH. Conversely, patients with RVD had a higher burden of pre-existing cardiac comorbidities but no evidence of more severe SARS-CoV-2 infection compared with those without RVD. The presence of PH was associated with a higher rate of in-hospital death or ICU admission (41.7 vs 8.5%, p<0.001), while the presence of RVD was not (17.2 vs 11.7%, p=0.404). CONCLUSIONS: Among hospitalised non-ICU patients with COVID-19, PH (and not RVD) was associated with signs of more severe COVID-19 and with worse in-hospital clinical outcome. TRIAL REGISTRATION NUMBER: NCT04318366.
引用
- Pagnesi M, Baldetti L, Beneduce A, et al. Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19. Heart. 2020. PMID: 32675217. doi:10.1136/heartjnl-2020-317355
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。